Mast Cells Play a Key Role in Host Defense against Herpes Simplex Virus Infection through TNF-α and IL-6 Production  by Aoki, Rui et al.
Mast Cells Play a Key Role in Host Defense against
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IL-6 Production
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Kohji Moriishi5, Yukihiro Nishiyama2 and Shinji Shimada1
The essential contribution of mast cells (MCs) to bacterial host defense has been well established; however, little
is known about their role in viral infections in vivo. Here, we found that intradermal injection with herpes simplex
virus 2 (HSV-2) into MC-deficient KitW/Wv mice led to increased clinical severity and mortality with elevated virus
titers in HSV-infected skins. Ex vivo HSV-specific tetramer staining assay demonstrated that MC deficiency did not
affect the frequency of HSV-specific cytotoxic T lymphocytes (CTLs) in draining lymph nodes. Moreover, the high
mortality in KitW/W-v mice was completely reversed by intradermal reconstitution with bone marrow–derived MCs
(BMMCs) from wild-type, but not TNF / or IL-6 / mice, indicating that MCs or, more specifically, MC-derived
tumor necrosis factor (TNF) and IL-6 can protect mice from HSV-induced mortality. However, HSV did not directly
induce TNF-a or IL-6 production by BMMCs; supernatants from HSV-infected keratinocytes induced the
production of these cytokines by BMMCs without degranulation. Furthermore, IL-33 expression was induced
in HSV-infected keratinocytes, and blocking the IL-33 receptor T1/ST2 on BMMCs significantly reduced TNF-a and
IL-6 production by BMMCs. These results indicate the involvement of MCs in host defense at HSV-infected sites
through TNF-a and IL-6 production, which is induced by keratinocyte-derived IL-33.
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INTRODUCTION
Mast cells (MCs) are not only effector cells in allergic
responses but are also initiator and regulator cells in both
innate and adaptive immune responses (Galli et al., 2005).
They are widely distributed throughout the body, in particular
at host/environmental interfaces such as the skin and airways,
where they preferentially localize around nerves and blood
vessels (Galli et al., 2005). They can therefore act as important
sentinels for the immune system and control effective innate
responses against invading pathogens by releasing various
mediators, including a diverse array of cytokines, chemokines,
and lipid mediators (Metz and Maurer, 2007; Abraham and St
John, 2010).
The development of MC-deficient mouse models allows
testing of MC contribution to biological responses of interest,
both through the analysis of experimental outcomes in MC-
deficient mice and those in mice in which MC deficiency has
been selectively repaired by local engraftment (Galli et al.,
2005; Metz and Maurer, 2007). Using this so-called ‘‘MC
knock-in mouse’’ model, several studies have demonstrated
that MCs are critical effector cells in eliciting protective
immune responses against bacteria, and that MC-derived
tumor necrosis factor-a (TNF-a) is largely responsible for
bacterial clearance by inducing neutrophil recruitment into
sites of infection (Echtenacher et al., 1996; Malaviya et al.,
1996). For the many MCs located proximal to blood vessels,
the release of factors such as other cytokines, histamine,
proteases, and chemokines also contributes to increased
local vascular permeability and recruitment of other
participants in the inflammatory response at the site of
infection (Abraham and St John, 2010).
In contrast to the well-established contributions of MCs to
host defense against bacteria, the function of MCs in antiviral
immunity has not been well defined. We and others have
previously reported that Toll-like receptor 3 (TLR3)-, TLR7-,
and TLR9-mediated activation of MCs can induce selective
production of cytokines and chemokines, suggesting that MCs
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are capable of secreting these mediators in response to
virus-derived pathogen-associated molecular patterns (Kulka
et al., 2004; Matsushima et al., 2004). Indeed, several viruses,
including dengue virus and adenovirus, have been shown to
activate MCs in vitro through TLR3, TLR7, and possibly other
mechanisms (Dawicki and Marshall, 2007). Nevertheless, the
in vivo contribution of MCs to host defense in viral infections
is less clear, mainly because suitable mouse models of viral
infection have not been tested in the ‘‘MC knock-in mouse’’
model until recently (Metz et al., 2008; Abraham and St John,
2010). However, two very recent studies have revealed the
in vivo role of MCs in protective immune responses against
viral infection using ‘‘MC knock-in mouse’’ model, and
demonstrated that natural killer (NK) and NK T-cell
recruitment promoted by MCs or MC-derived antimicrobial
peptides has a pivotal role in viral clearance during dengue
virus or vaccina virus infection, respectively (St John et al.,
2011; Wang et al., 2012).
Herpes simplex virus type 2 (HSV-2) is a sexually trans-
mitted pathogen that infects more than 500 million people
worldwide and causes most cases of genital herpes (Looker
et al., 2008). In cutaneous herpes simplex lesions of humans
and in murine models, keratinocytes, dendritic cells (DCs),
and infiltrating lymphocytes, especially HSV-specific CD8 T
lymphocytes, are known to have a central role in controlling
primary and recurrent HSV infections (Simmons and Tscharke,
1992; Chew et al., 2009). Moreover, the important role of
other innate immune effectors such as NK cells, NK T cells,
plasmacytoid DCs, macrophages, and gd T lymphocytes has
been recently re-emphasized, either in direct immune control
or via modulation of adaptive immune responses in HSV
infection (Cheng et al., 2000; Chew et al., 2009; Melchjorsen
et al., 2009). However, very little in vitro and in vivo data exist
regarding the role of MCs in HSV infections.
Here, we examined the in vivo contribution of MCs to the
immune responses against HSV using the ‘‘MC knock-in
mouse’’ model and demonstrated that MCs were critically
involved in host defense at HSV-infected sites through TNF-a
and IL-6 production. Our study also suggests an important role
for IL-33 derived from HSV-infected keratinocytes as a trigger
for the production of these inflammatory cytokines by MCs.
RESULTS
MC-deficient mice exhibit high mortality and local inflammation
following cutaneous HSV infection
We first assessed the role of MCs in vivo by using a murine
model of lethal HSV encephalitis (Corey and Spear, 1986),
whereby peripheral infection with HSV involves local
replication in the skin, followed by rapid dissemination of
the virus via sensory axons, causing zosteriform lesions to
spread from the primary inoculation site along the affected
dermatomes, and leading to paralysis and death. Using this
model, MC-deficient KitW/W-v mice and Kitþ /þ wild-type
(WT) mice were injected intradermally with HSV-2
(7.5104 PFU) and were monitored for survival and scored
for paralysis and skin lesions. Intriguingly, KitW/W-v mice
exhibited markedly decreased percent survival when
compared with Kitþ /þ mice (Figure 1a). We also compared
clinical severity in these mice by using the experimental
autoimmune encephalomyelitis score, which reflects paraly-
sis. The clinical score in KitW/W-v mice was significantly higher
than that in Kitþ /þ mice (Figure 1b). We obtained similar
findings when we repeated the experiments with MC-deficient
KitW-sh/W-sh mice injected intradermally with HSV-2
(Supplementary Figure S1a and b online). As shown in
Figure 1c, the zosteriform eruption in the skin lesions of
KitW/W-v mice appeared at an earlier time point, and exacer-
bated more rapidly and severely than that of Kitþ /þ mice.
Consistent with these findings, histological examination of the
zosteriform lesion in KitW/W-v mice revealed increased inflam-
mation and an extended infection area, as demonstrated by
HSV glycoprotein D antigen expression in subepithelial tissue,
when compared with that in Kitþ /þ mice, at 3 and 5 days
post infection (Figure 1d and e). On the basis of this
histopathological observation, we assessed whether MCs
contribute to HSV clearance by measuring virus titers in the
HSV-infected skins of Kitþ /þ and KitW/W-v mice. The virus titers
in KitW/W-v mice rapidly increased, reaching maximal levels at
day 5, and dropped afterward (Figure 1f). In contrast, the skin
lesions of Kitþ /þ mice contained lower virus titers, which were
sustained until day 7. These results suggested that the severe
inflammation and mortality observed in KitW/W-v mice may be
attributed to impaired virus clearance during these early stages
of HSV infection, particularly during the first 3 days.
MCs produce TNF-a and IL-6, but not IFN-a, in response to
soluble factors released from HSV-infected keratinocytes
The impaired clearance of HSV-2 in the skin lesion of KitW/W-v
mice was observed during the first 72 hours after infection
(Figure 1f), suggesting that MCs are involved in innate
immunity, rather than acquired immunity, against HSV-2. In
early immune responses in HSV infection, several studies
highlight the importance of TNF-a for protection against lethal
HSV encephalitis (Rossol-Voth et al., 1991; Lundberg et al.,
2007). In addition, TNF-a has been shown to control HSV
replication, independent of T and B cells (Feduchi et al., 1989;
Heise and Virgin, 1995). Other studies indicated that IL-6 and
IFN-a decrease the susceptibility to HSV infection (Murphy
et al., 2008; Melchjorsen et al., 2009). Consistent with these
findings, we could detect the production of TNF-a, IL-6, and
IFN-a at HSV-2 injection sites 72 hours after infection in WT
mice (Supplementary Figure S3a online). Therefore, we next
assessed whether HSV-2 directly induced cytokine production
by BMMCs. However, MCs are resistant to HSV-2 infection
(Supplementary Figure S4a online), and HSV-2 exposure did
not induce TNF-a and IL-6 production or degranulation by
BMMCs (Supplementary Figure S4b–d online).
Because the major cellular targets for HSV-2 were found
to be epidermal keratinocytes in the skin lesion of Kitþ /þ
and KitW/W-v mice at 3 days after infection Figure 1d), we
hypothesized that soluble factors released from HSV-infected
keratinocytes may induce the cytokine production by MCs.
Strikingly, as shown in Figure 2a and b, the supernatants of
HSV-treated keratinocytes, Pam-212, induced significant TNF-a
and IL-6 production by BMMCs in a multiplicity of infection
(MOI)–dependent manner, whereas they failed to induce
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degranulation in, and IFN-a production by, BMMCs (Figure 2c
and d). Notably, in vitro HSV infection of keratinocytes did not
directly induce the production of these cytokines
(Supplementary Figure S3b online). These results imply that
MCs may be capable of producing TNF-a and IL-6 in response
to cutaneous HSV-2 infection in vivo by indirect stimulation
via soluble factors derived from HSV-infected keratinocytes.
Interestingly, as shown in Supplementary Figure S2a and c
online, HSV-2 did not significantly increase MC degranulation
in the skin in vivo.
MCs, particularly MC-derived TNF-a and IL-6, protect mice from
HSV-induced severe mortality
To confirm whether the different responses against cutaneous
HSV-2 infection in Kitþ /þ and KitW/W-v mice observed in
Figure 1 reflect the lack of MCs in KitW/W-v mice rather than
other c-Kit-related differences (Galli et al., 2005), we
examined KitW/W-v mice locally reconstituted with BMMCs
derived from Kitþ /þ mice (WT BMMC-KitW/W-v). As
expected, the decreased survival rate and the severe clinical
and lesion score in HSV-infected KitW/W-v mice were
significantly improved by local reconstitution with MCs,
comparable to those in Kitþ /þ mice (Figure 3a–c). Never-
theless, local reconstitution of KitW/W-v mice with BMMCs
derived from TNF-deficient mice (TNF / BMMC-KitW/W-v)
or IL-6-deficient mice (IL-6 / BMMC-KitW/W-v) did not
significantly improve percent survival, clinical score, or lesion
score (Figure 3a–c). These results clearly indicate that both
MC-produced TNF and IL-6 critically contribute to protective
antiviral responses to HSV-2 in vivo.
IL-33 derived from HSV-2-treated keratinocytes can induce
cytokine production by MCs
Next, we explored which soluble factors released by HSV-2-
treated keratinocytes induce TNF-a and IL-6 production by
MCs. Recent studies have highlighted the important roles of
IL-33 as an ‘‘alarmin’’ in innate immune responses, as IL-33,
as a key product of epithelial barrier tissues such as the skin,
can be released into the extracellular space after epithelial cell
damage during infection or trauma, and it functions as an
alarmin to alert the immune system (Moussion et al., 2008;
Luthi et al., 2009). It is notable that IL-33 has recently been
shown to be upregulated in the lung during viral infection with
influenza virus and spleen during infection with lymphocytic
choriomeningitis virus (Chang et al., 2011; Bonilla et al.,
2012). In line with these findings, we found that increased
IL-33 expression was selectively detected on damaged or
degenerating Pam-212 cells after in vitro HSV-2 exposure, and
the frequency of IL-33-expressing cells was increased in an
MOI-dependent manner (Figure 4a). In addition, we found a
significant increase in IL-33 production by HSV-infected Pam-
212 cells (Figure 4a). Importantly, we found that IL-6 and TNF-
a production by BMMCs in response to the supernatants from
HSV-2-treated Pam-212 cells was significantly and most
effectively reduced by blockade of the IL-33 receptor using
the T1/ST2 antibody (Figure 4b). Conversely, IL-6 production
was not affected by neutralization of other cytokines
including IL-1a, IFN-b, and thymic stromal lymphopoietin
(Supplementary Figure S5 online). Furthermore, we found that
IL-33 stimulates the production of TNF-a and IL-6 by BMMCs
in a dose-dependent manner (Figure 4c), without inducing
degranulation (data not shown). On the basis of these results,
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Figure 2. Supernatants of herpes simplex virus 2 (HSV)–infected
keratinocytes induce tumor necrosis factor-a (TNF-a) and IL-6, but not IFN-a,
production by bone marrow–derived mast cells (BMMCs). BMMCs were
stimulated with culture supernatants (sup) from Pam-212 cells treated with or
without HSV at multiplicities of infection (MOIs) of 0.1, 1, 10, or 30, or with
lipopolysaccharide (LPS; 10 ng ml1) as a positive control for 24 hours,
and assessed for (a) TNF-a, (b) IL-6, and (c) IFN-a production by ELISA.
(d) b-Hexosaminidase (b-Hex) assay of BMMCs at 1 hour after stimulation with
the culture supernatants from Pam-212 cells treated with or without HSV at
MOIs of 0.1, 1, or 10 for 24 hours, or with ionomycin (1mM) for 10 minutes as a
positive control. **Po0.01 versus results for untreated Pam-212 cells. Data are
representative of three independent experiments, showing the means
(n¼ 3)±SD.
Figure 1. Mast cell (MC)-deficient mice exhibit increased clinical severity and mortality following cutaneous herpes simplex virus 2 (HSV-2) infection.
MC-deficient C57BL/6-KitW/W-v mice (white circles) and the corresponding wild-type (WT) C57BL/6-Kitþ /þ mice (black squares) (n¼ 8) were injected
intradermally with HSV-2 186 strain (7.5104 PFU) on the right back. (a) Survival rates, (b) mean clinical scores, (c, d) representative clinical photos and cross-
sections stained with anti-HSV antibody (Ab) or by hematoxylin and eosin (H&E) staining of HSV-infected skins (original magnification  200, scale bar¼ 100mm),
(e) quantification of the cell infiltrate in d throughout 10 high-power fields (HPFs) of view, and (f) HSV titers in the skin (n¼3) measured in plaque assays at the
indicated time points after HSV-2 inoculation are shown. gD, glycoprotein D. The results of Kitþ /þ mice at days 3 and 5 were below the limit of detection.
*Po0.05 and **Po0.01 versus the corresponding WT mice. Data are representative of at least three independent experiments with similar results, showing the
means (n¼ 3)±SD.
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we conclude that enhanced TNF-a and IL-6 production in
MCs by supernatants from HSV-2-infected keratinocytes is, at
least in part, mediated by IL-33 signaling.
MCs do not contribute to the induction of HSV-specific CD8þ
T cells
Previous studies revealed a significant role of CD8þ T cells in
controlling HSV infections (Simmons and Tscharke, 1992;
Chew et al., 2009). Recent studies in mice demonstrated that
migrating dermal CD103þ and langerin-expressing DCs are
the major transporters of HSV antigens out of skin and,
together with resident CD8þ DCs, are the major antigen-
presenting cells of HSV antigens to CD8þ T cells in draining
lymph nodes (DLNs) (Allan et al., 2003; Bedoui et al., 2009).
Therefore, we assessed the number of HSV-gB-specific CD8þ
T cells by using tetramer staining, as well as CD8aþ DCs and
langerinþ DCs, in DLNs of Kitþ /þ and KitW/W-v mice after
intradermal infection with HSV. The proportions of HSV-gB-
specific CD8þ T cells in the DLNs of HSV-infected Kitþ /þ
and KitW/W-v mice at 6 days after infection were significantly
increased when compared with that of uninfected mice
(Figure 5a). However, the numbers of HSV-gB-specific
CD8þ T cells in Kitþ /þ and KitW/W-v mice were comparable
(Figure 5b), suggesting that MCs are not essential for the
generation of HSV-specific CD8þ T cells in primary cuta-
neous HSV-2 infection. Consistent with these findings, there
was no significant difference in the frequency of CD8aþ DCs
or langerinþ DCs in DLNs of Kitþ /þ and KitW/W-v mice at 2 or
5 days after infection, respectively (Figure 5c). Similarly, no
significant difference was detected in the number of CD4þ
CD25þ Foxp3þ regulatory T cells found in DLNs (Figure 5d).
These results suggest that the impaired clearance of HSV-2 at
the infection site observed in KitW/W-v mice (Figure 1e) may
not be attributed to the impaired induction of HSV-specific
cytotoxic T lymphocytes (CTLs).
DISCUSSION
In this study, we have identified previously unknown functions
of skin MCs in host protection against HSV-2. The contribution
of MCs to host defense against HSV, one of the most common
viral infections in the world, had been less clear, probably
because MCs are resistant to HSV-2 infection. Indeed, recent
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Figure 3. Reconstitution with bone marrow–derived mast cells (BMMCs) derived from wild-type (WT) but not TNF / or IL-6 / mice prevents mortality in
KitW/W-v mice. (a) Survival rates, (b) clinical (experimental autoimmune encephalomyelitis (EAE)) scores, (c) lesion scores, and representative clinical photographs
of skin lesions of KitW/W-v mice (white circles), WT Kitþ /þ mice (black squares), WT BMMC-reconstituted KitW/W-v mice (gray circles), TNF / BMMC-
reconstituted KitW/W-v mice (white triangles), and IL6 / BMMC-reconstituted KitW/W-v mice (white lozenges) at the indicated time points after intradermal
injection with herpes simplex virus 2 (HSV-2; 7.5 104 PFU) are shown. TNF, tumor necrosis factor. *Po0.05 and **Po0.01 versus C57BL/6-KitW/W-v mice. Data
are representative of three independent experiments; n¼ 10 mice/group.
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studies have shown MC involvement in viral host defense, in
which the infection of MCs with the virus, such as dengue
virus or vaccina virus, is required for MC-mediated immune
responses (St John et al., 2011; Wang et al., 2012). Unlike
these viral infection models, we demonstrated that MCs are
critically involved in viral host defense against HSV-2, even
though relatively few HSV-2-infected MCs were detected
in vitro and in vivo (Supplementary Figure S3a online and
data not shown). We also report that MC deficiency resulted in
impaired HSV-2 clearance at the infection sites during the first
72 hours after infection, suggesting that MCs have key roles as
the first line of defense against HSV-2 rather than contributing
to acquired immunity. Using ‘‘MC knock-in mouse’’ model,
we also demonstrated the crucial contribution of MC-pro-
duced TNF-a and IL-6 to protective antiviral responses to
HSV-2. Several previous studies suggested an antiviral
mechanism involving TNF-a and IL-6 that is responsible for
a direct reduction in viral replication or for increasing local
infiltration of innate immune cells at the site of HSV infection
(Feduchi et al., 1989; Rossol-Voth et al., 1991; Heise and
Virgin, 1995; Lundberg et al., 2007; Murphy et al., 2008). In
addition, the infiltrating cells, including plasmacytoid DCs,
neutrophils, and NK cells, and their products including key
antiviral cytokines IFN-a/b, may also provide other means of
limiting HSV replication and eliminating virus-infected cells
(Melchjorsen et al., 2009).
A recent study revealed that MC-dependent CTL responses
are important for an optimized host defense, such as protec-
tion against intracellular bacteria, because MCs can interna-
lize, process, and present bacterial antigens and induce
antigen-specific activation and proliferation of CD8þ T cells
upon infection with Listeria monocytogenes (Stelekati et al.,
2009). In our model of cutaneous HSV-2 infection, however,
HSV-specific CTL generation in MC-deficient mice was not
impaired. It is possible that differences in pathogens or their
infection levels in MCs might explain the differences in MC
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contribution for CTL generation among these infection
models. Nevertheless, in our model, it is still possible that
MCs are involved in the recruitment of CTLs to the sites of
HSV infection, because CD8þ T-cell recruitment to sites of
infection is facilitated by MCs during infection with Newcastle
disease virus (Orinska et al., 2005). Further detailed analysis
under different viral infection is needed to reveal the functions
and significance of MCs for CTL responses against viral
infection.
The results of our study show that IL-33 derived from
epidermal keratinocytes damaged by viral infection has a
critical role in triggering the production of inflammatory
cytokines by MCs. Although several viruses have been shown
to infect and/or activate MCs in vitro, we observe neither
significant HSV-2 infection nor HSV-induced direct activation
of BMMCs monitored by cytokine production and degranula-
tion. In contrast, the culture supernatants from HSV-2-treated
keratinocytes, as well as IL-33 alone, induced TNF-a and IL-6
production by MCs independent of degranulation. The effect
of the supernatants from HSV-2-treated keratinocytes was
reduced consistently and most effectively by blockade of
IL-33–IL-33R signaling in MCs. In addition, although we have
recently reported that extracellular adenosine 50-triphosphate
also mediates ‘‘danger signal’’ derived from the damaged
keratinocytes (Kawamura et al., 2012), hydrolyzing
extracellular adenosine 50-triphosphate contained in the
supernatants by soluble ecto-nucleoside triphosphate diphos-
phohydrolase (NTPDase; apyrase) did not affect TNF-a and
IL-6 production by MCs (data not shown). These results
clearly indicate the importance of IL-33 as an ‘‘alarmin’’ in
cutaneous HSV infection. Our findings also suggest that IL-33
may be important for other cutaneous virus infections, such as
varicella, hand–foot–mouse disease, warts, molluscum, and
so on, which also induce the damage or degeneration of
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Figure 5. Mast cells (MCs) are not essential for the generation of herpes simplex virus 2 (HSV)–specific CD8þ T cells. KitW/W-v and Kitþ /þ mice were injected
with HSV-2, as described in Figure 1. Draining lymph nodes (DLNs) were harvested at (a, b) 6, (c) 2 or 5, and (d) 3 days after infection. (a) The percentages of
CD8þ HSV gBþ T cells in DLNs of HSV-2-infected and -uninfected mice were analyzed by flow cytometry using major histocompatibility complex (MHC) class I
tetramer specific for HSV peptide glycoprotein B (gB) or tyrosinase-related protein 2 (TRP2) as a negative control (data not shown). (b) The number of CD8þ HSV
gBþ T cells in DLNs. (c) The number of CD103þ CD205þ dendritic cells (DCs) at 5 days after infection and CD8aþ DCs at 2 days after infection in DLNs. (d) The
number of CD4þ CD25þ Foxp3þ regulatory T-cell population in DLNs. *Po0.05 and **Po0.01 versus the corresponding uninfected mice. Data are
representative of two independent experiments, showing the means (n¼ 5 mice/group)±SD.
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keratinocytes. Further studies are needed to determine
whether there is a significant in vivo role for IL-33 as an
‘‘alarmin’’ in viral infections other than HSV-2.
MATERIALS AND METHODS
Mice
Female c-Kit-mutant genetically MC-deficient C57BL/6-KitW/W-v
(KitW/W-v) mice and the congenic normal C57BL/6-Kitþ /þ (Kitþ /þ )
mice were purchased from Japan SLC (Hamamatsu, Japan). C57BL/6-
KitW-sh/W-sh (KitW-sh/W-sh) mice were obtained from Sankyo Labo
Service (Tokyo, Japan). C57BL/6-Tnf / mice and C57BL/6-IL-6 /
mice were purchased from The Jackson Laboratory (Bar Harbor,
ME). All animal experiments were carried out in strict accordance
with the recommendations in Guidelines for Proper Conduct of
Animal Experiments of Science Council of Japan. The protocol was
approved by University of Yamanashi Animal Care and Use
Committee (permit number: 19–50).
Virus
The WT HSV-2 strain 186 was prepared in Vero cells as described
previously (Ushijima et al., 2009), and stored at  80 1C with an
approximate titer of 1 107 PFU per ml.
HSV inoculation of mice
Kitþ /þ mice, KitW/W-v mice, and KitW-sh/W-sh mice were injected
intradermally with HSV-2 (7.5 104–7.5 105 PFU in 50ml of EMEM;
Nissui, Tokyo, Japan ) on the right lower flank after shaving under
diethyl ether anesthesia. Mice were then monitored for survival and
scored for skin lesions and paralysis. Clinical score was assessed using
the experimental autoimmune encephalomyelitis score, and skin
lesions were scored as described previously (Takasaki et al., 2000).
Measurement of viral titers and cytokines in HSV-2-inoculated
skin
KitW/W-v mice or Kitþ /þ mice were intradermally infected with
7.5 104 PFU of HSV-2 186 strain (n¼ 3) on the right back. The
primary inoculation site of skin (8 8 mm) was excised at 1, 3, 5, or 7
days after infection, respectively. Skin samples were thawed and
homogenized in 2 ml of Dulbecco’s phosphate-buffered saline (Invi-
trogen, Carlsbad, CA) containing protease inhibitors (Thermo Scien-
tific, Waltham, MA) with sea sand on ice, centrifuged at 7,000 r.p.m.
for 5 minutes, and the supernatants were added on Vero cell mono-
layers. After 24 hours, cultures were fixed with 5% formalin, stained
with 0.05% crystal violet, and plaques were counted using a dissecting
microscope. For measurement of cytokines, skin samples were excised
and homogenized in 250ml of Tper EDTA-free lysis buffer (Pierce)
containing protease inhibitors (Thermo Scientific). Cytokine screening
was performed in the supernatants using the Multi-Analyte ELISArray
Kit (SABiosciences, Fredrick, MD) according to the manufacturer’s
instructions.
Preparations of BMMCs
BMMCs were prepared from B6 mice BM cell suspensions, as
described previously (Matsushima et al., 2004). Briefly, crude BM
cells (4 105 cells per ml) were cultured in complete RPMI-1640
(Invitrogen) in the presence of murine recombinant IL-3 (10 ng ml 1)
and recombinant stem cell factor (10 ng ml 1; PeproTech, Boston,
MA). Nonadherent and loosely adherent cells were recovered
twice a week, and further expanded in fresh medium for 4 to 6
weeks. The resulting MC preparations contained 495% CD45þ
CD117þ cells.
In vitro HSV infection of BMMCs and keratinocytes
For HSV-2 infection of keratinocytes, 1 105 Pam-212 keratinocytes
were exposed to HSV-2 strain 186 at an MOI of 0.1, 1, 10, or 30 for
1 hour and washed three times. At 24 hours after incubation, the
culture supernatants were collected and passed through a filter
(Minisart high flow, pore size 0.1mm; Sartorius Stedim Biotech,
Goettingen, Germany) to remove free virus. For HSV-2 infection of
MCs, 2 105 BMMCs were infected for 1 hour with HSV-2 at an MOI
of 0.1, 1, or 10. Following infection, cells were washed three times
and then incubated for an additional 24 hours. In some experiments,
BMMCs were stimulated with the culture supernatants from Pam-212
cells, treated with or without HSV for 1 hour, or were stimulated with
lipopolysaccharide from E. coli serotype 0111:B4, containing o1%
protein and o1% RNA (10–100 ng ml 1, Sigma-Aldrich, St Louis,
MO) for 24 hours, as control. In the blocking experiments, the culture
supernatants from HSV-infected (MOI 30) Pam-212 cells were
pretreated with 20mg ml 1 of anti-IL-1a (R&D Systems, Minneapolis,
MN), IFN-b (Abcam, Cambridge, UK), and thymic stromal lympho-
poietin (R&D Systems) mAbs or isotype-matched control IgG mAbs
(BD Pharmingen, San Diego, CA) for 15 minutes before addition to
BMMCs. For blocking IL-33-mediated signals, BMMCs were preincu-
bated with 40mg ml 1 of anti-T1/ST2 mAb (MABioproducts, Walk-
erville, MD) or isotype control mAb for 30 minutes before addition of
the culture supernatants from HSV-infected Pam-212 cells. BMMCs
were stimulated for 6 hours with the supernatants, washed three
times, and incubated in their growth medium for an additional
24 hours. In some experiments, BMMCs were stimulated with control
IgG (100 ng ml 1), recombinant IL-33 (0.1–100 ng ml 1, R&D Sys-
tems), or lipopolysaccharide (10 ng ml) for 24 or 48 hours. The levels
of IL-1a, IL-6, TNF-a, IFN-a, IL-12, and IL-17 in the culture super-
natants were determined using an ELISA kit (BD Pharmingen and
eBiosciences, San Diego, CA) or the Multi-Analyte ELISArray Kit
(SABiosciences) according to the manufacturer’s instructions.
Degranulation assay
Degranulation was assessed by b-hexosaminidase assay, as described
previously (Matsushima et al., 2004). Briefly, the supernatants were
incubated with 2.5 mM p-nitrophenyl-N-acetyl b-D glucosaminide
(Sigma-Aldrich) for 90 minutes. The reactions were terminated by
0.4 M glycine, and the colored products were measured using an
ELISA plate reader (Molecular Devices, Sunnyvale, CA).
Local MC reconstitution in KitW/W-v mice
Four-week-old KitW/W-v mice were transfused by intradermal injection
with 2 106 BMMCs in 50ml of RPMI derived from Kitþ /þ , Tnf / ,
or Il-6 / mice as previously described (Grimbaldeston et al., 2007).
At 9 weeks after intradermal transfer, the BMMC-reconstituted KitW/W-v
mice were used for experiments.
Flow cytometry
Cells were stained with allophycocyanin (APC)-labeled anti-CD3,
FITC- or phycoerythrin (PE)-anti-CD8, APC-anti-CD11c, FITC-anti-
CD205, and PE-anti-CD103 mAbs (10mg ml 1, Pharmingen, San
Diego, CA) for 30 minutes at 4 1C and analyzed on a FACSCalibur
R Aoki et al.
Mast Cells Play a Key Role in HSV Infection
www.jidonline.org 2177
(Becton Dickinson, Franklin Lakes, NJ). For tetramer staining, inguinal
and axillary lymph nodes at 6 days after infection were stained with
PE-H-2Kb HSV-1gB498-505 (SSIEFARL) tetramer, or PE-H-2Kb TRP2
tetramer (5mg ml 1, MBL, Nagoya, Japan) as control, for 20 minutes
at 4 1C. To detect regulatory T cells or HSV-2-infected BMMCs, cells
were fixed and permeabilized with Cytofix/Cytoperm reagents (BD
Biosciences-Pharmingen), and then stained with APC-anti-Foxp3
mAb using the Foxp3 Staining Set (eBioscience) or FITC-anti-HSV
glycoprotein D mAb (Argene, Verniolle, France), respectively.
Immunohistochemistry
Skin tissues were collected from infected sites at 1, 3, or 5 days after
HSV infection and fixed in formalin. Paraffin-embedded sections were
dewaxed and rehydrated through graded concentrations of ethanol.
Tissue sections were stained with hematoxylin–eosin. Otherwise, the
sections were preincubated with 3% hydrogen peroxide in methanol
for 10 minutes to inactive endogenous peroxidase. Sections were
incubated with rabbit anti-HSV-2 polyclonal antibody or control
rabbit Ig for 1 hour at room temperature using the Dako envision kit
(Dako, Glostrup, Denmark). The sections were washed and incubated
with a goat anti-rabbit Ig conjugated to peroxidase-labeled dextran
polymer for 1 hour at room temperature. After wash, they were
treated with the chromogenic indicator dye 3,3’-diaminobenzidine
for 5 minutes, and then counterstained with Mayer’s hematoxylin. For
IL-33 staining, plated Pam-212 cells exposed to HSV for 24 hours
were washed and stained with goat anti-mouse IL-33 polyclonal
antibody (R&D Systems) at 10mg ml 1 for 3 hours at room tempera-
ture using the Dako LSAB kit (Dako). Cells were incubated with
biotinylated anti-goat secondary antibody, and then incubated with
peroxidase-conjugated streptavidin for 30 minutes. After development
with 3,3’-diaminobenzidine substrate, cells were counterstained with
Mayer’s hematoxylin.
Statistical analyses
The GraphPad Prism 5 software (GraphPad Software, La Jolla, CA)
was used to determine the statistical significance of survival data. Log-
rank test was used for comparison of survival curves. Other data were
analyzed by Student’s t-test.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We thank Kazutoshi Harada and Naotaka Shibagaki for their helpful discus-
sions, Hajime Suto for KitW-sh/W-sh mice, and Miyuki Ogino for technical
assistance. These studies were supported in part by a grant from the Ministry of
Education and Science of the Japanese Government (grant 10377541, http://
kaken.nii.ac.jp). The funder had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at http://
www.nature.com/jid
REFERENCES
Abraham SN, St John AL (2010) Mast cell-orchestrated immunity to pathogens.
Nat Rev Immunol 10:440–52
Allan RS, Smith CM, Belz GT et al. (2003) Epidermal viral immunity induced
by CD8alphaþ dendritic cells but not by Langerhans cells. Science
301:1925–8
Bedoui S, Whitney PG, Waithman J et al. (2009) Cross-presentation of viral and
self antigens by skin-derived CD103þ dendritic cells. Nat Immunol
10:488–95
Bonilla WV, Frohlich A, Senn K et al. (2012) The alarmin interleukin-33 drives
protective antiviral CD8 T cell responses. Science 335:984–9
Chang YJ, Kim HY, Albacker LA et al. (2011) Innate lymphoid cells mediate
influenza-induced airway hyper-reactivity independently of adaptive
immunity. Nat Immunol 12:631–8
Cheng H, Tumpey TM, Staats HF et al. (2000) Role of macrophages in
restricting herpes simplex virus type 1 growth after ocular infection. Invest
Ophthalmol Vis Sci 41:1402–9
Chew T, Taylor KE, Mossman KL (2009) Innate and adaptive immune
responses to herpes simplex virus. Viruses 1:979–1002
Corey L, Spear PG (1986) Infections with herpes simplex viruses (1). N Engl J
Med 314:686–91
Dawicki W, Marshall JS (2007) New and emerging roles for mast cells in host
defence. Curr Opin Immunol 19:31–8
Echtenacher B, Mannel DN, Hultner L (1996) Critical protective role of mast
cells in a model of acute septic peritonitis. Nature 381:75–7
Feduchi E, Alonso MA, Carrasco L (1989) Human gamma interferon and tumor
necrosis factor exert a synergistic blockade on the replication of herpes
simplex virus. J Virol 63:1354–9
Galli SJ, Kalesnikoff J, Grimbaldeston MA et al. (2005) Mast cells as ‘‘tunable’’
effector and immunoregulatory cells: recent advances. Annu Rev Immu-
nol 23:749–86
Grimbaldeston MA, Nakae S, Kalesnikoff J et al. (2007) Mast cell-derived
interleukin 10 limits skin pathology in contact dermatitis and chronic
irradiation with ultraviolet B. Nat Immunol 8:1095–104
Heise MT, Virgin HWt (1995) The T-cell-independent role of gamma interferon
and tumor necrosis factor alpha in macrophage activation during murine
cytomegalovirus and herpes simplex virus infections. J Virol 69:904–9
Kawamura T, Ogawa Y, Nakamura Y et al. (2012) Severe dermatitis with loss
of epidermal Langerhans cells in human and mouse zinc deficiency. J Clin
Invest 122:722–32
Kulka M, Alexopoulou L, Flavell RA et al. (2004) Activation of mast cells by
double-stranded RNA: evidence for activation through Toll-like receptor 3.
J Allergy Clin Immunol 114:174–82
Looker KJ, Garnett GP, Schmid GP (2008) An estimate of the global prevalence
and incidence of herpes simplex virus type 2 infection. Bull World Health
Organ 86:805–12
Lundberg P, Welander PV, Edwards CK 3rd et al. (2007) Tumor necrosis factor
(TNF) protects resistant C57BL/6 mice against herpes simplex virus-
induced encephalitis independently of signaling via TNF receptor 1 or 2.
J Virol 81:1451–60
Luthi AU, Cullen SP, McNeela EA et al. (2009) Suppression of interleukin-33
bioactivity through proteolysis by apoptotic caspases. Immunity 31:
84–98
Malaviya R, Ikeda T, Ross E et al. (1996) Mast cell modulation of neutrophil
influx and bacterial clearance at sites of infection through TNF-alpha.
Nature 381:77–80
Matsushima H, Yamada N, Matsue H et al. (2004) TLR3-, TLR7-, and TLR9-
mediated production of proinflammatory cytokines and chemokines from
murine connective tissue type skin-derived mast cells but not from bone
marrow-derived mast cells. J Immunol 173:531–41
Melchjorsen J, Matikainen S, Paludan SR (2009) Activation and evasion of
innate antiviral immunity by herpes simplex virus. Viruses 1:737–59
Metz M, Maurer M (2007) Mast cells–key effector cells in immune responses.
Trends Immunol 28:234–41
Metz M, Siebenhaar F, Maurer M (2008) Mast cell functions in the innate skin
immune system. Immunobiology 213:251–60
Moussion C, Ortega N, Girard JP (2008) The IL-1-like cytokine IL-33 is
constitutively expressed in the nucleus of endothelial cells and epithelial
cells in vivo: a novel ‘alarmin’? PLoS One 3:e3331
Murphy EA, Davis JM, Brown AS et al. (2008) Effect of IL-6 deficiency on
susceptibility to HSV-1 respiratory infection and intrinsic macrophage
antiviral resistance. J Interferon Cytokine Res 28:589–95
R Aoki et al.
Mast Cells Play a Key Role in HSV Infection
2178 Journal of Investigative Dermatology (2013), Volume 133
Orinska Z, Bulanova E, Budagian V et al. (2005) TLR3-induced activation of
mast cells modulates CD8þ T-cell recruitment. Blood 106:978–87
Rossol-Voth R, Rossol S, Schutt KH et al. (1991) In vivo protective effect of
tumour necrosis factor alpha against experimental infection with herpes
simplex virus type 1. J Gen Virol 72(Pt 1):143–7
Simmons A, Tscharke DC (1992) Anti-CD8 impairs clearance of herpes
simplex virus from the nervous system: implications for the fate of virally
infected neurons. J Exp Med 175:1337–44
Stelekati E, Bahri R, D’Orlando O et al. (2009) Mast cell-mediated antigen
presentation regulates CD8þ T cell effector functions. Immunity 31:
665–76
St John AL, Rathore AP, Yap H et al. (2011) Immune surveillance by mast cells
during dengue infection promotes natural killer (NK) and NKT-cell
recruitment and viral clearance. Proc Natl Acad Sci USA 108:9190–5
Takasaki I, Andoh T, Shiraki K et al. (2000) Allodynia and hyperalgesia induced
by herpes simplex virus type-1 infection in mice. Pain 86:95–101
Ushijima Y, Goshima F, Kimura H et al. (2009) Herpes simplex virus type 2
tegument protein UL56 relocalizes ubiquitin ligase Nedd4 and has a role
in transport and/or release of virions. Virol J 6:168
Wang Z, Lai Y, Bernard JJ et al. (2012) Skin mast cells protect mice against
vaccinia virus by triggering mast cell receptor S1PR2 and releasing
antimicrobial peptides. J Immunol 188:345–57
R Aoki et al.
Mast Cells Play a Key Role in HSV Infection
www.jidonline.org 2179
